FDA Restricts J&J’s COVID-19 Vaccine Due to Blood Clot Risk



    Name*
    Email*
    Message

    FDA Restricts J&J’s COVID-19 Vaccine Due to Blood Clot Risk

    U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to the ongoing risk of rare but serious blood clots • Full Story

    U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to the ongoing risk of rare but serious blood clots.

    The Food and Drug Administration said the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J’s vaccine. U.S. authorities for months have recommended that Americans starting their COVID-19 vaccinations use the Pfizer or Moderna shots instead.

    FDA officials said in a statement that they decided to restrict J&J’s vaccine after taking another look at data on the risk of life-threatening blood clots within two weeks of vaccination.

    53

    Tags: ,

    Add Comment

    *Only proper comments will be allowed

    Related Posts:

    FDA Restricts J&J’s COVID-19 Vaccine Due to Blood Clot Risk



      Name*
      Email*
      Message